CORC

在结果中检索

CORC

浏览/检索结果: 共52条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Development and validation of a radiomics-based method for macrovascular invasion prediction in hepatocellular carcinoma with prognostic implication 会议论文
美国圣地亚哥, 2019年2月20日
作者:  Wei Jingwei;  Fu Sirui;  Zhang Shuaitong;  Zhang Jie;  Gu Dongsheng
收藏  |  浏览/下载：73/0  |  提交时间：2019/05/08
THE IMPACT OF COEXISTING HEPATIC STEATOSIS (HS) ON DEVELOPMENT OF CIRRHOSIS,HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT AND HBsAg SEROCLEARANCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) 会议论文
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, NOV 08-12, 2019
作者:  Li, Jie;  Yang, Hwai-I;  Le, An;  Henry, Linda;  Hoang, Joseph
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/31
Deep Learning Based Classification for Metastasis of Hepatocellular Carcinoma with Microscopic Images 会议论文
San Diego, USA, 2019.2.16-2019.2.21
作者:  Meng, Hui;  Gao, Yuan;  Wang, Kun;  Tian, Jie
收藏  |  浏览/下载：5/0  |  提交时间：2020/04/29
Differences in presentation and management patterns in patients with hepatocellular carcinoma (HCC) between China and Singapore: Initial data from the HCC Registry in Asia. 会议论文
作者:  Chow, Pierce K. H.;  Li, Lequn;  Li, Jiangtao;  Tan, Poh-Seng;  Jia, Fan
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Phase II trial of tepotinib vs sorafenib for treatment-naive advanced hepatocellular carcinoma (HCC) in Asian patients 会议论文
作者:  Ryoo, B-Y.;  Ren, Z.;  Kim, T-Y.;  Pan, H.;  Rau, K-M.
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
A randomized multicentered phase II study to evaluate SHR-1210 (PD-1 antibody) in subjects with advanced hepatocellular carcinoma (HCC) who failed or intolerable to prior systemic treatment 会议论文
作者:  Qin, S. K.;  Ren, Z. G.;  Meng, Z. Q.;  Chen, Z. D.;  Chai, X. L.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
Phase II trial of tepotinib vs sorafenib in Asian patients (pts) with advanced hepatocellular carcinoma (HCC) 会议论文
作者:  Ryoo, B-Y.;  Ren, Z.;  Kim, T-Y.;  Pan, H.;  Rau, K-M.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Sustained virologic response (SVR) to direct-acting antiviral (DAA) therapy in patients with chronic hepatitis C virus (HCV) infection and hepatocellular carcinoma (HCC): a systematic review and meta-analysis 会议论文
作者:  Ji, F.;  Wei, M. T.;  Yeo, Y. H.;  Wei, B.;  Ogawa, E.
收藏  |  浏览/下载：3/0  |  提交时间：2019/11/19
A randomized multicentered phase II study to evaluate SHR-1210 (PD-1 antibody) in subjects with advanced hepatocellular carcinoma (HCC) who failed or intolerable to prior systemic treatment 会议论文
作者:  Qin, S. K.;  Ren, Z. G.;  Meng, Z. Q.;  Chen, Z. D.;  Chai, X. L.
收藏  |  浏览/下载：3/0  |  提交时间：2019/11/19
A randomized multicentered phase II study to evaluate SHR-1210 (PD-1 antibody) in subjects with advanced hepatocellular carcinoma (HCC) who failed or intolerable to prior systemic treatment 会议论文
ANNALS OF ONCOLOGY, 2018-10-01
作者:  Qin, S. K.;  Ren, Z. G.;  Meng, Z. Q.;  Chen, Z. D.;  Chai, X. L.
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace